Urban and Insular Study on Treatment Experiences and Stigma in People Living with HIV

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

300 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-03-01

Study Completion Date

2026-02-27

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Study Title: SUNRISE Study: Urban and Island Experiences of HIV Treatment and Stigma

What is this study about? This study aims to understand how living in urban areas versus islands affects the experiences of people living with HIV (PLWH) in Portugal. Specifically, the investigators want to explore how stigma and mental health (such as depression and anxiety) differ between these two settings. The investigators are also interested in understanding how the number of pills a person takes daily (called "pill burden") impacts their mental health and satisfaction with treatment.

Why is this study important? Stigma related to HIV can make it harder for people to stick to their treatment and can negatively affect their mental health and overall well-being. By comparing urban and island settings, the investigators hope to identify unique challenges faced by PLWH in different environments. This information will help the investigators to develop better strategies to support people living with HIV, no matter where they live.

Who can participate? Adults (18 years or older) who have been diagnosed with HIV. People who have been on antiretroviral therapy (HIV treatment) for at least six months.

Individuals living in urban areas or island region.

What will happen during the study?

Participants will complete a one-time interview during their regular HIV care visit. The interview will include questions about:

Their experiences with HIV-related stigma. Their mental health (including depression and anxiety). Their satisfaction with their current HIV treatment. The number of pills they take daily and how this affects their daily life. All information will be kept confidential, and participation is voluntary.

What are the potential benefits of participating? This study will help to understand the challenges faced by people living with HIV in different parts of Portugal. This knowledge can lead to improved support services and treatment options for PLWH in the future.

What are the risks of participating? There are no physical risks associated with this study. However, some questions may touch on sensitive topics, such as stigma or mental health.

How will the results be used? The results of this study will be shared with the scientific community, healthcare providers, and organizations that support people living with HIV. The goal is to use this information to improve care and reduce stigma for PLWH in Portugal and beyond.

Who is conducting this study? This study is led by researchers from the Faculty of Medicine of Lisbon, in collaboration with hospitals in Portugal mainland, the Azores, and Madeira.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Stigma, Social Support and Quality of Life

NCT05781204

HIV Infections

COMPLETED

Intervention to Improve HIV Care Retention by Addressing Stigma Stigmatized Environments

NCT05110963

HIV I Infection

ACTIVE_NOT_RECRUITING NA

Improving HIV Prevention Skills in People With Serious Mental Illnesses

NCT00356291

HIV/AIDS

COMPLETED PHASE2

Efficacy Testing of a Culturally Relevant Stigma Intervention With WLWH in Tanzania

NCT05033002

HIV Stigma, Social Self Efficacy +3 more

COMPLETED NA

Study Among People Living With HIV and Their Health Professionals of Associated Factors of Resilience to Self-stigma

NCT05149001

HIV Infections

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

HIV Stigma Depression/Anxiety

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Urban Cohort

People living with HIV (PLWH) who receive care in urban centers.

No interventions assigned to this group

Island Cohort

People living with HIV (PLWH) who receive care in island regions (Azores and Madeira).

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Individuals diagnosed with HIV
* Aged 18 years or older.
* On antiretroviral therapy (ART) for at least six months.
* On a daily oral treatment regimen (single or multiple pills).
* Able to provide informed consent.

Exclusion Criteria

* Individuals under 18 years of age.
* Individuals who have switched antiretroviral regimen in the previous six months.
* Individuals unable to provide informed consent (e.g., due to cognitive impairment or lack of capacity).
* Individuals with limited understanding of the study procedures or questionnaires (e.g., language barriers or cognitive limitations).
* Individuals who are incarcerated or deprived of liberty.
* Pregnant individuals.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No